Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to rise 93.33% to -28 cents per share on March 13

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q4'24

Est.

$-0.29

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.12

Q1'24

Missed

by $0.52

Q4'23

Missed

by $0.27

The last earnings report on November 13 showed earnings per share of -15 cents, beating the estimate of -28 cents. With 5.08K shares outstanding, the current market capitalization sits at 71.83M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

5005 McConnell Avenue

Phone

+1 310 665-2928

Employees

Web

https://www.armatapharma.com